The OptiSeq™ Colorectal Cancer Panel 43-Gene Detection Test is a Research-Use-Only (RUO) product that can be used in research settings to profile CRC patients for different mutations. These studies may provide important information for mechanism of CRC development studies and comparison of mutations developed for different demographic backgrounds.
Colorectal Cancer
BRAF (B-raf proto-oncogene), CTNNB1 (Catenin (cadherin-associated protein), beta 1), EGFR (Epidermal growth factor receptor), FBXW7 (F-Box And WD Repeat Domain Containing 7), GNAS (GNAS Complex Locus), HER-2 (Human epidermal growth factor receptor 2)
See More ...